SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-11-056096
Filing Date
2011-12-05
Accepted
2011-12-05 13:57:59
Documents
7
Period of Report
2011-12-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PDL BIOPHARMA, INC 8-K 12-5-2011 form8k.htm 8-K 24594
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 56933
3 image1.jpg GRAPHIC 10939
4 image2.jpg GRAPHIC 25225
5 image3.jpg GRAPHIC 12625
6 image4.jpg GRAPHIC 11572
7 signature.jpg GRAPHIC 4900
  Complete submission text file 0001140361-11-056096.txt   173225
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 111242673
SIC: 2836 Biological Products, (No Diagnostic Substances)